Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/9/2025

Treatment of Rheumatoid Arthritis Flare in the Hand

First-Line Treatment for RA Flare

  • The American College of Rheumatology recommends low-dose glucocorticoids (≤10 mg/day of prednisone or equivalent) for RA disease flares to provide rapid symptom relief 1, 2
  • Glucocorticoids should be used at the lowest possible dose and for the shortest possible duration (less than 3 months) to provide the best benefit-risk ratio 1
  • The risk/benefit ratio of glucocorticoid therapy is favorable as long as the dose is low and the duration of therapy is short 1

Concurrent DMARD Management

  • For patients already on DMARDs, the American College of Rheumatology recommends continuing current DMARD therapy while managing the flare with glucocorticoids 1, 3
  • For patients on methotrexate (MTX) monotherapy with persistent disease activity, consider optimizing MTX dose (15-25 mg/week as tolerated) 3, 4
  • Adding sulfasalazine (SSZ) and hydroxychloroquine (HCQ) for triple-DMARD therapy is also recommended for patients with persistent disease activity 3, 4

Local Treatment Options

  • For inflammatory activity predominantly in hand joints, consider intra-articular glucocorticoid injection 4, 5
  • This approach is particularly useful when flare is limited to one or a few joints 4

Treatment Monitoring and Goals

  • The treatment target should be low disease activity or remission 1, 2
  • Monitor disease activity using tender and swollen joint counts, patient and physician global assessments, and composite measures like Clinical Disease Activity Index (CDAI) 6
  • Assess response to therapy within 1-3 months and adjust treatment if target is not achieved 6